Trent:₹3,256.10+30.96 (+0.96%)
Reliance Industries:₹1,377.50+1.93 (+0.14%)
Adani Ports:₹1,917.00-0.19 (-0.01%)
Tata Consumer:₹1,155.90+11.90 (+1.04%)
Titan Company:₹4,620.00-79.90 (-1.70%)
TCS:₹2,376.20+33.50 (+1.43%)
Trent:₹3,256.10+30.96 (+0.96%)
Reliance Industries:₹1,377.50+1.93 (+0.14%)
Adani Ports:₹1,917.00-0.19 (-0.01%)
Tata Consumer:₹1,155.90+11.90 (+1.04%)
Titan Company:₹4,620.00-79.90 (-1.70%)
TCS:₹2,376.20+33.50 (+1.43%)
Refer & Earn
Arihant Plus App

Arihant Plus App

Clinitech Laboratory Ltd

Clinitech Lab | 544220

Market Closed
₹32.72
₹1.43 (-4.19%)
As on 22/11/26, 11:26 PM
Market Cap--- CR
Current Price₹---
High / Low₹--- / ---
PE Ratio19.13
Book Value₹40.52
Dividend Yield0.00%
ROCE6.92%
ROE4.65%
Face Value₹2.00
Current Vol.---
Average Vol.---
ISININE0QMR01015
PB Ratio0.86
Debt to Equity0.03
Net Profit Margin4.32
Operating Margin12.43

- Share Price Chart

+₹0.00 (+0.00%)6M

Stock Performance

₹34.15₹32.75
₹32.72
Previous CloseToday's Open
₹28.55₹47.15
₹32.72
52W Low52W High
₹32.75Today's Open
₹34.15Previous Close
13,200Volume
₹28.5552W Low
₹47.1552W High

Ratios

No data available

About Company

  • Clinitech Laboratory Limited was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 with the Registrar of Companies, Mumbai and was converted to Public Limited on August 25, 2023
  • The Company is in the business of healthcare services providing quality services such as pathology testing laboratories, diagnostic centers, scan centers, X-ray and ECG clinics, etc
  • The Company established a new Lab in Kalyan in 2012, NABL Accreditation at Airoli Centre in 2016, a new Lab at Thane in 2018
  • Besides these, the Company conduct more than 150 tests including Biochemistry, Immunology, Hematology, Molecular Biology tests, urine analysis, Serology, Microbiology and Histopathology tests
  • Clinical pathology is a medical specialty that focuses on the diagnosis of diseases and conditions through the analysis of bodily fluids and tissues
  • It includes various laboratory tests and techniques such as blood tests, urine analysis, and tissue biopsies to help healthcare professionals understand the underlying causes of a patient's symptoms and guide treatment decisions
  • Clinical pathologists play a crucial role in interpreting test results and providing valuable information to aid in patient care
  • Imaging diagnosis or radiology involves imaging procedures such as X-rays and ultrasounds that help determine anatomical or physiological changes inside a patient's body, thus assisting doctors in diagnosing
  • It includes more complex tests such as CT scans, MRIs, and highly specialized PET-CT scans
  • The Company issued and allotted 6,02,400 equity shares of Rs 10 each and raised funds, comprising a fresh issue of Rs 5

Research Calls

Research Calls
Locked Access

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSIN/A
SMA 20N/A
SMA 50N/A
SMA 100N/A
SMA 200N/A
SMA 10N/A
MACD_12_26_DaysN/A
EMA10DayN/A
EMA20DayN/A
EMA50DayN/A
MACD_12_26_9_DaysN/A
EMA100DayN/A
EMA200DayN/A

Pivot Points

Volume Analysis
📊

No Information Available

Volume Analysis data is not available at this time.

Growth Rate

Revenue Growth15.31%
ROE4.54%
EBITDA Margin12.43%

All figures in ₹ Crores

Indicators20262025
Revenue
9.49
8.23
Interest
0.07
0.06
Expenses
8.50
7.40
Financing Profit
1.18
1.06
Financing Margin %
12%
13%
Other Income
0.19
0.23
Depreciation
0.51
0.45
Profit before tax
0.60
0.55
Tax %
30%
29%
Net Profit
0.41
0.39
EPS in Rs
1.83
1.90
Show % Change
ShareHolding
📊

No Information Available

No shareholding data available at this time.

📊

No Data Available

No Block Deals data available for this company.

News

📊

No Information Available

No news available for this company.
Record Date
Corporate Action
Information
Announcement Day
24 Sept 2026
AGM
AGM
22 Aug 2026
23 Sept 2025
AGM
AGM
26 Aug 2025

Peers

LTP(₹)
Market Cap(₹ Cr.)
P/E Ratio(Ratio)
P/B Ratio(Ratio)
Cash Earnings(Ratio)
Debt to Equity(Ratio)
Net Profit Ratio(%)
33
7
18
1
8
0
4.32%
9,190
1,32,139
58
12
42
1
7.94%
1,080
1,05,080
74
9
55
0
17.23%
702
92,366
95
6
53
1
8.87%
780
67,960
123
9
75
1
9.20%
825
62,284
58
6
40
0
11.20%
1,481
39,829
62
9
44
0
12.56%
1,945
39,757
44
8
27
1
10.21%
2,007
33,680
56
12
43
0
18.45%
797
33,483
165
9
57
2
6.20%
Showing 10 of 71 Results

Frequently Asked Questions

What is Share Price of Clinitech Laboratory Ltd?

The current share price of Clinitech Laboratory Ltd (Clinitech Lab) is ₹32.72. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Clinitech Laboratory Ltd?

The Price-to-Earnings (P/E) ratio of Clinitech Laboratory Ltd is 18.64. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Clinitech Laboratory Ltd?

Clinitech Laboratory Ltd has a 52-week high of ₹47.15 and a 52-week low of ₹28.55. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Clinitech Laboratory Ltd?

Clinitech Laboratory Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Clinitech Laboratory Ltd?

The Earnings Per Share (EPS) of Clinitech Laboratory Ltd is ₹1.83. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Clinitech Laboratory Ltd?

Clinitech Laboratory Ltd has a Return on Equity (ROE) of 4.65%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

mobile

Ready to invest smarter?
Download the app today.

GET IT ON

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

DOWNLOAD ON THE

App Store

4.2